检索

期
标题
作者
编号 4 (2024)
Characteristics of consultations for patients aged over 45 years
Dubrovina S.
PDF
(Rus)
编号 4 (2024)
The concept of epigenetic modifications in fetal metabolic programming
Tezikov Y., Lipatov I., Tyutyunnik V., Kan N., Kurbanova A.
PDF
(Rus)
编号 4 (2023)
Excess adipose tissue and chronic subclinical inflammation in patients with polycystic ovary syndrome
Kirillova E., Krechetova L., Vtorushina V., Ivanets T., Chernukha G.
PDF
(Rus)
编号 2 (2023)
Cardiometabolic risk factors in women undergoing the menopausal transition and the potential of drospirenone-containing contraceptive in the correction of the identified abnormalities
Tolstov S., Salov I., Rebrov A.
PDF
(Rus)
编号 2 (2023)
Association between new coronavirus infection and fetal growth restriction
Lipatov I., Tezikov Y., Kalinkina O., Tyutyunnik V., Kan N., Majorova M., Yakovleva M.
PDF
(Rus)
编号 9 (2023)
The effect of myoinositol and D-chiroinositol in a ratio of 40:1 on hormonal and metabolic parameters in women with polycystic ovary syndrome
Pustotina O., Rasulova I.
PDF
(Rus)
编号 9 (2023)
Clinical and pathogenetic rationale for two-stage prevention of preeclampsia in high-risk women using an insulin sensitizer for preconception preparation
Tezikov Y., Lipatov I., Zumorina E., Azamatov A., Tyutyunnik V., Kan N., Chekalovets A., Borisova A., Golodnova A.
PDF
(Rus)
编号 1 (2022)
Role of insulin resistance in the mechanisms of adaptation and development of female reproductive system disease
Lipatov I., Tezikov Y., Tyutyunnik V., Kan N., Kuzmina A., Zumorina E., Amosov M.
PDF
(Rus)
编号 2 (2022)
Inositol and human reproduction
Pustotina O., Dikke G., Ostromensky V.
PDF
(Rus)
编号 10 (2021)
Body mass index, body composition, and metabolic profile of patients with polycystic ovary syndrome
Chernukha G., Miroshina E., Kuznetsov S., Ivanov I.
PDF
(Rus)
编号 3 (2020)
The role of gut microbiota in the development of gestational diabetes mellitus
Onopriychuk A., Kapustin R., Arzhanova O.
PDF
(Rus)
编号 12 (2016)
CHRONIC SYSTEMIC INFLAMMATION AND MITOCHONDRIAL DYSFUNCTION IN THE ORIGIN OF POLYCYSTIC OVARY SYNDROME
Khashchenko E., Tsvirkun D.
PDF
(Rus)
编号 4 (2011)
ENDOCRINE AND METABOLIC FEATURES IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME
SUKHIKH G., BIRYUKOVA A., NAZARENKO T., DURINYAN E.
PDF
(Rus)
编号 2 (2022)
Role of insulin resistance in the mechanisms of adaptation and development of disease in postpartum and early neonatal periods
Lipatov I., Tezikov Y., Tyutyunnik V., Kan N., Kuzmina A., Zumorina E., Yakusheva A.
PDF
(Rus)
编号 1 (2021)
CARBOHYDRATE AND LIPID METABOLISM AND OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH MENSTRUAL IRREGULARITIES AND OBESITY
GLAZKOVA O., SHMELEVA S.
PDF
(Rus)
编号 11 (2019)
The specific features of the course of acute vulvovaginal candidiasis and its therapy with fenticonazole in reproductive-aged women with different phenotypes of polycystic ovary syndrome
Abashova E., Yarmolinskaya M., Misharina E.
PDF
(Rus)
编号 4 (2016)
Vitamin D and metabolic syndrome risk in patients with reproductive dysfunction
Maltseva L., Gafarova E.
PDF
(Rus)
编号 6 (2009)
Infertility and polycystic ovary syndrome
Orazmuradova L., Orazmuradov A., Payendi F., Khapayeva A.
编号 4 (2022)
Preeclampsia as a separate gestational clinical and pathogenetic form of insulin resistance syndrome
Tezikov Y., Lipatov I., Azamatov A., Tyutyunnik V., Kan N., Zumorina E., Kuzmina A.
PDF
(Rus)
编号 12 (2020)
Inositol and lipoic acid in the treatment of insulin resistance in women with polycystic ovary syndrome
Pustotina O.
PDF
(Rus)
编号 11 (2019)
Androgen profile in patients with polycystic ovary syndrome and its association with metabolic dysfunction
Chernukha G., Naidukova A., Udovichenko M., Kaprina E., Ivanets T.
PDF
(Rus)
编号 4 (2016)
Significance of vitamin D deficiency correction in the combination treatment of metabolic disorders in patients with polycystic ovary syndrome
Matveeva M., Samoilova J.
PDF
(Rus)
编号 6 (2009)
Present views of insulin resistance outside and during pregnancy
Shibanova Y., Murashko L., Degtyareva Y.
编号 5 (2021)
Current aspects of the role of insulin resistance, systemic inflammation, and oxidative stress in the pathogenesis of hyperandrogenism and abnormal folliculogenesis in patients with polycystic ovary syndrome
Belova I., Khashchenko E., Uvarova E.
PDF
(Rus)
编号 5 (2019)
Gestational diabetes mellitus and obstetric complications
Zagarskikh E., Kurashova N.
PDF
(Rus)
编号 3 (2016)
DEVELOPMENT OF POLYCYSTIC OVARY SYNDROME: GENETIC ASPECTS
Naidukova A., Kaprina E., Donnikov A., Chernukha G.
PDF
(Rus)
编号 1 (2023)
The role of vitamin D and omega-3 polyunsaturated fatty acid deficiencies in the pathogenesis of polycystic ovary syndrome
Abashova E., Yarmolinskaya M.
PDF
(Rus)
编号 3 (2021)
Effectiveness of a differentiated approach to the treatment of patients with polycystic ovary syndrome using inositols and combined oral contraceptives in early reproductive age
Khashchenko E., Nadzharyan A., Uvarova E.
PDF
(Rus)
编号 4 (2019)
Clinical and molecular genetic determinants of the development of gestational diabetes mellitus
Khodzhaeva Z., Snetkova N., Klimenchenko N., Abramova M., Degtyareva E., Donnikov A.
PDF
(Rus)
编号 6 (2016)
Obesity and female reproductive health
Aganezova N., Aganezov S.
PDF
(Rus)
编号 7 (2022)
RELATIONSHIP BETWEEN LIPID METABOLISM AND INSULIN RESISTANCE IN GESTATIONAL DIABETES MELLITUS
AFONINA V., BATRAK N., MALYSHKINA A., SOTNIKOVA N.
PDF
(Rus)
编号 5 (2021)
Gestational diabetes mellitus: screening and diagnostic criteria in early pregnancy
Abramova M., Khodzhaeva Z., Gorina K., Muminova K., Goryunov K., Ragozin A., Silachev D.
PDF
(Rus)
编号 1 (2019)
Endocrine and clinical aspects of inositol in polycystic ovarian syndrome
Dubrovina S., Krasilnikova L.
PDF
(Rus)
编号 12 (2015)
ROLE OF WEIGHT LOSS IN THE TREATMENT OF REPRODUCTIVE DISORDERS IN WOMEN
Kuznetsova I., Uspenskaya Y., Vedzizheva E., Vasilyeva I.
PDF
(Rus)
编号 9 (2021)
Gestational diabetes mellitus
Volkova N., Davidenko I., Degtyareva Y.
PDF
(Rus)
编号 3 (2021)
Identity of preeclampsia and metabolic syndrome clinical manifestations: searching for substantiation
Lipatov I., Tezikov Y., Azamatov A., Shmakov R.
PDF
(Rus)
编号 10 (2017)
Role of systemic inflammation in the development of pregnancy complications in obese women
Chabanova N., Mataev S., Vasilkova T., Shevlyukova T.
PDF
(Rus)
编号 8 (2015)
Systemic inflammation and insulin resistance in the pathogenesis of polycystic ovary syndrome
Rasin M., Zhitnik V.
PDF
(Rus)
编号 9 (2020)
Pregnancy is a natural model of metabolic syndrome: results of a dynamic study of physiological gestation
Lipatov I., Tezikov Y., Shmakov R., Azamatov A., Martynova N.
PDF
(Rus)
编号 8 (2021)
Relationship between the severity of endothelial dysfunction and metabolic disorders and the severity of climacteric syndrome
Tolstov S., Salov I., Rebrov A.
PDF
(Rus)
编号 3 (2021)
Polycystic ovary syndrome and gut microbiota
Chernukha G., Miroshina E., Priputnevich T.
PDF
(Rus)
编号 7 (2017)
Indicators of mitochondrial functioning in adolescent girls with polycystic ovary syndrome with regard to the presence of metabolic disorders and overweight
Khashchenko E., Sukhanova Y., Pyataeva S., Volodina M., Tarasova N., Tsvirkun D., Uvarova E., Vysokikh M.
PDF
(Rus)
编号 5 (2011)
ANALYSIS OF THE ASSOCIATIONS OF GENE POLYMORPHISMS WITH POLYCYSTIC OVARY SYNDROME AND ENDOCRINE AND METABOLIC DISTURBANCES
SUKHIKH G., BIRYUKOVA A., NAZARENKO T., ZAKHARZHEVSKAYA N., DURINYAN E., GENEROZOV E., GOVORUN V.
PDF
(Rus)
1 - 43 的 43 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##